Universal Flu mRNA Vaccine: Promises, Prospects, and Problems.

Area of Science:

• Vaccinology
• Virology
• Molecular Biology

Background:

• Seasonal flu vaccines are the primary method for preventing influenza epidemics.
• Current vaccines have limited efficacy due to the high diversity of influenza viruses.
• Recent advancements in vaccine technology, spurred by the coronavirus pandemic, offer new possibilities.

Purpose of the Study:

• To review the current state of universal influenza vaccine development.
• To explore the potential of novel RNA-based vaccine platforms for influenza.
• To suggest future research directions for RNA-based flu vaccines.

Main Methods:

• Review of recent scientific literature on influenza vaccines.
• Analysis of first-in-human studies of chimeric hemagglutinin-based vaccines.
• Examination of messenger RNA (mRNA) and self-amplifying RNA (saRNA) flu vaccine candidates in clinical and preclinical trials.

Main Results:

• A chimeric hemagglutinin-based universal influenza vaccine has shown promising initial results in human studies.
• Numerous mRNA and saRNA influenza vaccines are in development, demonstrating the potential of these platforms.
• The effectiveness and applicability of these novel RNA approaches for a universal influenza vaccine are still under investigation.

Conclusions:

• RNA vaccine platforms represent a significant advancement with potential for universal influenza vaccines.
• Further research is needed to clarify the role and efficacy of RNA-based strategies in combating influenza.
• The development of a universal flu vaccine remains a critical goal in public health.